MESOTHELIOMA | 2026-11-02

Proving Asbestos Causation: The Frequency-Regularity-Proximity Test and California’s Substantial-Factor Standard

Federal courts ask whether exposure was frequent, regular, and proximate. California asks whether it was a substantial factor in raising the risk. The difference decides mesothelioma cases.

Mesothelioma and other asbestos diseases present a hard causation problem. The disease appears decades after exposure, a patient may have encountered many asbestos products made by many companies, and no one can point to the single fiber that started the cancer. Courts have built doctrines to decide

Every asbestos case turns on causation — the link between a particular defendant’s product and the plaintiff’s disease. The challenge is that mesothelioma has a latency of decades, a worker may have been exposed to dozens of asbestos-containing products, and medical science cannot identify which exposure triggered the malignancy. Courts needed a workable rule that neither lets every defendant escape because no single fiber can be traced, nor holds a defendant liable for a trivial, incidental exposure. Two approaches emerged. The federal courts coalesced around the frequency-regularity-proximity test of Lohrmann v. Pittsburgh Corning Corp. (4th Cir. 1986) 782 F.2d 1156. California adopted the substantial-factor standard of Rutherford v. Owens-Illinois, Inc. (1997) 16 Cal.4th 953. The two overlap, but they are not the same, and the difference matters to California plaintiffs.

The Causation Problem in Asbestos Cases

Asbestos disease defies the ordinary model of proving causation. In a car crash, the mechanism and timing are clear. In mesothelioma, the exposure that mattered may have occurred forty or fifty years earlier, the plaintiff likely cannot recall every product he worked with, and the medical consensus is that the disease results from cumulative exposure rather than a single identifiable dose. A rule demanding that a plaintiff prove which specific fiber from which specific product caused the cancer would make recovery impossible and reward the very uncertainty the defendants’ products created.

At the same time, courts were unwilling to impose liability on a defendant whose product contributed only a trivial or speculative amount to a worker’s lifetime exposure. The doctrines that developed try to strike that balance: requiring proof of a meaningful exposure to a defendant’s product, while recognizing the cumulative, latent nature of the disease.

The Lohrmann Frequency-Regularity-Proximity Test

In Lohrmann, the Fourth Circuit adopted what has become the most widely used federal standard. To support an inference that exposure to a defendant’s product was a substantial factor in causing disease, a plaintiff must show exposure to that product with sufficient frequency, regularity, and proximity. In other words, the plaintiff must present evidence that he worked with or near the defendant’s asbestos product on a frequent and regular basis, and in physical proximity close enough to inhale fibers released by it.

The Lohrmann test screens out casual or minimal contact. Evidence that a defendant’s product was merely present somewhere at a large worksite, without proof that the plaintiff worked near it with any regularity, is not enough. The test gives courts a concrete framework — how often, how regularly, how close — to evaluate whether an exposure was substantial enough to go to a jury. Many jurisdictions have adopted or adapted this framework, making it the dominant federal approach to asbestos causation.

California’s Substantial-Factor Standard: Rutherford

California charted its own course in Rutherford v. Owens-Illinois. The California Supreme Court held that a plaintiff need not prove that fibers from a particular defendant’s product were the ones that actually caused the malignant cell transformation. Instead, the plaintiff must prove that exposure to the defendant’s product was a substantial factor in contributing to the aggregate dose of asbestos the plaintiff inhaled, and hence to the risk of developing asbestos-related cancer.

This is a crucial reformulation. By tying causation to whether the exposure was a substantial factor in increasing the risk of disease — rather than demanding proof of which fiber caused the cancer — Rutherford accommodated the medical reality of cumulative dose and long latency. A plaintiff shows causation by proving a reasonable medical probability that the defendant’s product contributed to the overall exposure that caused the disease. California thus focuses on the defendant’s contribution to aggregate risk, a standard well suited to the scientific understanding of how asbestos disease develops.

Lineaweaver, McGonnell, and the Threshold of Proof

California’s standard still requires real evidence of exposure to each defendant’s product. In Lineaweaver v. Plant Insulation Co. (1995) 31 Cal.App.4th 1409, the Court of Appeal explained that a plaintiff must establish some threshold exposure to the defendant’s defective products, and a reasonable medical probability that the exposure was a factor in causing the injury. Mere presence of a product at a site, without evidence connecting the plaintiff to it, does not suffice — a point echoing the concerns behind Lohrmann.

McGonnell v. Kaiser Gypsum Co. (2002) 98 Cal.App.4th 1098 reinforced the point. There, the evidence that the plaintiff was exposed to the defendant’s asbestos product was too speculative — a theoretical possibility that the product was somewhere the plaintiff worked, without evidence he actually encountered it. The court held that such speculation cannot establish causation even under California’s standard. Together, Lineaweaver and McGonnell show that Rutherford lowered the bar from proving the specific causative fiber, but did not eliminate the requirement of actual, provable exposure to each defendant’s product.

Comparing the Two Approaches

The federal and California approaches share a goal and differ in emphasis. Both require more than a product’s mere presence at a worksite. Both reject the impossible demand that a plaintiff identify the single causative fiber. But the Lohrmann test frames the inquiry around the pattern of contact — frequency, regularity, proximity — as a proxy for whether an exposure was substantial. California’s Rutherford standard frames it around the defendant’s contribution to the aggregate dose and risk, asking whether that contribution was a substantial factor.

In practice, California’s formulation can be more favorable to plaintiffs, because it expressly accommodates the cumulative-dose model and does not require the plaintiff to satisfy a rigid frequency-regularity-proximity checklist for every defendant. A California plaintiff who can show genuine exposure to a defendant’s product, and medical evidence that such exposure contributes to risk, can reach a jury even where the pattern of contact might be debated under the federal test. But the plaintiff must still prove that genuine exposure; McGonnell makes clear that conjecture is not enough.

What This Means for Building a California Asbestos Case

For a California mesothelioma plaintiff, the causation standard dictates the evidence to gather. The case is built on proof of exposure to each defendant’s product — through the plaintiff’s own testimony, co-worker testimony, product identification, job-site records, and industrial-hygiene and medical experts who explain how the exposures contributed to the aggregate dose and the risk of disease. The goal is not to isolate one fiber but to show, defendant by defendant, a substantial contribution to the cumulative exposure that caused the cancer.

This is demanding work, often reconstructing a work history that spans decades and employers long gone. But it is the work Rutherford requires, and it is why experienced asbestos counsel invest heavily in product identification and exposure reconstruction. A well-built exposure record, tied to credible medical testimony on cumulative risk, is what carries a California asbestos case past summary judgment and to a jury.

Expert Testimony and the "Every Exposure" Debate

Causation in an asbestos case is proven through expert testimony — typically an industrial hygienist who reconstructs the plaintiff’s exposures and a medical expert who connects those exposures to the disease. One recurring battleground is the so-called "every exposure" theory, under which a plaintiff’s expert opines that every identifiable exposure above background contributed to the aggregate dose and therefore to the risk. Defendants attack this theory as unscientific, arguing that it would make every defendant liable regardless of how small its contribution, and that it skips the dose analysis that Rutherford requires.

California courts have navigated this debate with the Rutherford framework and the gatekeeping principles of expert admissibility. Under Sargon Enterprises, Inc. v. University of Southern California (2012) 55 Cal.4th 747, trial courts act as gatekeepers excluding expert opinion that is speculative or lacks a reasoned basis. An opinion that a particular exposure contributed to the aggregate dose must rest on evidence of actual exposure and a reasoned explanation of how it contributed — not a bare assertion that any exposure counts. The expert must tie the opinion to the plaintiff’s real exposure history and the science of cumulative dose, which is precisely the inquiry Rutherford framed.

The practical consequence is that expert preparation is decisive. A medical and industrial-hygiene case built on documented exposures, a quantitative or semi-quantitative sense of dose, and a reasoned causation opinion survives both a Sargon challenge and the defense’s "every exposure" critique. An opinion that leans on the slogan without the underlying exposure proof is vulnerable. California’s standard rewards the plaintiff who does the work of proving exposure and explaining dose, and it gives defendants a legitimate tool against opinions that substitute a catchphrase for analysis.

Summary Judgment and the Threshold Showing

Many asbestos cases are decided not at trial but on summary judgment, where a defendant argues that the plaintiff cannot produce evidence of exposure to its product sufficient to reach a jury. This is where the threshold-showing requirement from Lineaweaver and the anti-speculation rule from McGonnell do their real work. A defendant moving for summary judgment contends that the plaintiff has no non-speculative evidence connecting the plaintiff to the defendant’s product — that, at most, the product might have been present somewhere the plaintiff worked.

To defeat such a motion, the plaintiff must come forward with specific evidence of exposure: testimony identifying the defendant’s product at the plaintiff’s worksite and in the plaintiff’s work, records tying the product to the relevant time and place, or co-worker accounts of the plaintiff’s contact with it. Evidence that merely raises the possibility of exposure is not enough; McGonnell holds that a plaintiff who can show only that a product was conceivably present has not met the threshold. The plaintiff need not prove the precise dose, but must offer more than conjecture that the plaintiff encountered the product at all.

This threshold is where product identification investigation pays off. The depositions of the plaintiff and co-workers, the gathering of employment and job-site records, and the reconstruction of the work history are what produce the specific exposure evidence that defeats summary judgment. A case that invests in that investigation reaches the jury under Rutherford; a case that cannot connect the plaintiff to a defendant’s product with more than speculation does not, regardless of how serious the disease.

Applying the Standard to Product and Premises Defendants

The causation analysis applies to different kinds of defendants in distinct ways. Against a product manufacturer, the question is whether the plaintiff was exposed to that manufacturer’s asbestos-containing product with enough contact to be a substantial factor in the aggregate dose — a classic product-identification inquiry. Against a premises owner, the question is whether asbestos conditions on the owner’s property exposed the plaintiff, which raises additional doctrines about the duty a landowner owes to workers and, in the contractor context, the limits the Privette line of cases places on that duty.

The take-home exposure cases add another dimension. Where a worker carried asbestos fibers home on clothing and a family member developed disease from that secondary exposure, California has recognized that a duty may extend to household members in appropriate circumstances. These cases still require proof that the exposure was a substantial factor under Rutherford, but they extend the universe of plaintiffs beyond the directly exposed worker to those exposed through that worker’s contaminated clothing and belongings.

The distinctions among defendants are not merely academic. A single plaintiff may sue a dozen manufacturers, a shipyard or industrial premises owner, and an employer that supplied asbestos products, and the causation theory against each must be developed on its own facts. A product that was ubiquitous at one job site may have been absent at another, and the premises owner’s liability turns on conditions it controlled rather than on products it made. Matching each defendant to the correct legal theory, and proving the substantial-factor exposure for each, is the organizing task of the entire case. In every variation, the Rutherford substantial-factor standard supplies the causation backbone, while the surrounding doctrines — duty, premises liability, take-home foreseeability — shape which defendants can be reached and on what theory. A well-built California asbestos case matches each defendant to the right theory and proves, for each, the genuine exposure that the substantial-factor standard requires. That combination of a plaintiff-sensitive causation rule and a demanding exposure-proof requirement is what makes California both a favorable and a rigorous forum for asbestos litigation.

Frequently Asked Questions

Why is causation so hard to prove in asbestos cases?

Mesothelioma appears decades after exposure, a worker may have encountered many asbestos products, and medical science cannot identify the single fiber that caused the cancer. Courts developed special causation doctrines to decide these cases fairly despite that uncertainty.

What is the frequency-regularity-proximity test?

It is the federal standard from Lohrmann v. Pittsburgh Corning (4th Cir. 1986) 782 F.2d 1156. A plaintiff must show exposure to the defendant’s asbestos product with sufficient frequency, regularity, and physical proximity to support an inference that the exposure was a substantial factor in causing disease.

What standard does California use?

California uses the substantial-factor standard from Rutherford v. Owens-Illinois (1997) 16 Cal.4th 953. A plaintiff must show that exposure to the defendant’s product was a substantial factor in contributing to the aggregate dose of asbestos and thus to the risk of developing the disease.

Does California require proof of which fiber caused the cancer?

No. Rutherford expressly rejects that requirement. The plaintiff shows a reasonable medical probability that the defendant’s product contributed to the overall exposure causing the disease, not that its fibers were the specific ones that transformed the cell.

Is it enough that a defendant’s product was present at the worksite?

No. Under both standards, mere presence is not enough. Lineaweaver (1995) 31 Cal.App.4th 1409 and McGonnell (2002) 98 Cal.App.4th 1098 require actual, provable exposure to the defendant’s product; speculation that the plaintiff might have encountered it does not establish causation.

Is California’s standard better for plaintiffs?

Often, yes. California’s focus on contribution to aggregate dose and risk accommodates the cumulative-exposure model and does not impose a rigid frequency-regularity-proximity checklist. But the plaintiff must still prove genuine exposure to each defendant’s product.

What evidence proves exposure in a California case?

Plaintiff and co-worker testimony, product identification, job-site and employment records, and industrial-hygiene and medical experts who connect the exposures to the aggregate dose and the risk of disease. The case is built defendant by defendant.

How does latency affect my case?

Because the disease can appear forty to fifty years after exposure, the case often requires reconstructing a long-past work history. California’s statutes of limitation for asbestos disease are tied to diagnosis and disability rather than the date of exposure, reflecting that latency.

Related Guides

Speak With a California Mesothelioma Attorney

If you or a loved one has been diagnosed with mesothelioma or another asbestos disease, proving causation against the responsible companies is the heart of the case. Trembach Law Firm builds the exposure record California law requires and holds manufacturers and premises owners accountable. Call (213) 645-2246 for a confidential consultation. Anatolii Trembach holds an LL.M. and is admitted to the California Bar.

This article is for general informational purposes only and does not constitute legal advice. Asbestos causation is highly fact-specific; consult a qualified attorney about your particular exposure history.

Contact Trembach Law Firm at (818) 514-7680 for a confidential consultation.

Trembach Law Firm | 27001 Agoura Road, Suite 350, Calabasas, CA 91301